TABLE 2.
Total number of dietary supplement projects and funding by the NIH and USDA for the top health outcomes in the CARDS database, FY 1999–20071
| Outcome | NIH total funding, USD, millions | NIH DS2 funding, % | USDA total funding, USD, millions | USDA DS funding, % |
| Cancer | 615.0 | 33 | 100.5 | 29 |
| Cardiovascular system | 350.2 | 19 | 123.5 | 36 |
| Cellular/molecular mechanisms | 350.5 | 19 | 59.1 | 17 |
| Women's reproductive health | 260.1 | 14 | 32.2 | 9 |
| Immune function | 192.6 | 10 | 60.8 | 18 |
| Musculoskeletal system | 164.9 | 9 | 60.6 | 17 |
| Aging | 165.4 | 9 | 88.8 | 26 |
| Nutrient requirements and metabolism | 88.7 | 5 | 123.1 | 36 |
| Unspecified3 | 147.0 | 8 | 11.4 | 3 |
| Digestive and gastrointestinal system | 105.8 | 6 | 24.2 | 7 |
| Diabetes | 81.6 | 5 | 40.3 | 12 |
| Antioxidant function | 57.1 | 3 | 61.6 | 18 |
| Pediatrics | 57.3 | 3 | 53.2 | 15 |
| Obesity | 54.0 | 3 | 56.1 | 16 |
1
Percentages are calculated using the total number of projects per agency 1999–2007. Percentages total more than 100% because projects may be included in more than one category.
2
DS, dietary supplement.
3
Project abstract does not describe a specific health outcome being studied.